CPT 64655 BAT Lead Revision Reimbursement | OpenPayer

Summary & Overview

CPT 64655: Baroreflex Activation Therapy Lead Revision or Replacement

CPT code 64655 represents revision or replacement of only the lead of a baroreflex activation therapy (BAT) system, including intraoperative interrogation and programming. This code is used when direct work is performed on the implanted lead without replacing the full neurostimulation generator. The code is clinically important because BAT is an established therapy for select patients with resistant hypertension or heart failure symptoms managed with neuromodulation, and accurate coding affects claims processing, device management workflows, and national utilization tracking.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of CPT code 64655, including clinical context, typical service settings, and what elements the code bundles (lead revision plus intraoperative interrogation/programming). The publication provides benchmarks where available, notes on common billing scenarios, and guidance on documentation elements that typically support use of this code. It also summarizes related coding considerations and potential areas for payer policy updates that affect coverage and prior authorization requirements.

This summary is intended for clinicians, coding professionals, and revenue cycle stakeholders seeking a focused, national-level briefing on CPT code 64655 and its role in reporting BAT lead revision procedures.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare64655CPTbaroreflex activation therapyneurostimulationdevice revisionlead replacementsurgical procedureintraoperative programming

Billing Code Overview

CPT code 64655 describes a procedure in which the provider revises or replaces only the lead of a baroreflex activation therapy (BAT) system. The service includes intraoperative interrogation and programming of the system as part of the lead revision or replacement.

Service type: Surgical lead revision/replacement for a neurostimulation device (baroreflex activation therapy).
Typical site of service: Hospital operating room or ambulatory surgical center where device revision and intraoperative programming can be performed.

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 68-year-old patient with resistant hypertension or heart failure previously implanted with a baroreflex activation therapy (BAT) system presents with lead malfunction evidenced by loss of capture, intermittent high impedance, or pain at the lead site. The treating clinician evaluates device interrogation data in clinic and confirms lead failure requiring revision or replacement of the lead only. The patient is scheduled for a minor operative procedure in an outpatient surgical suite or ambulatory surgery center. Intraoperative steps include preoperative device interrogation, exposure of the existing lead, removal of the malfunctioning lead segment or complete lead extraction if needed, implantation of a replacement lead segment, intraoperative interrogation and programming of the BAT system to confirm appropriate sensing and stimulation thresholds, hemostasis, and wound closure. The procedure is coded to 64655 for revision or replacement of only the lead of a baroreflex activation therapy system and includes intraoperative interrogation and programming. Typical site of service is an ambulatory surgery center or hospital outpatient department; inpatient status is uncommon unless complications or comorbidities require admission. Typical clinicians involved include neuromodulation-trained cardiac electrophysiologists, vascular surgeons, or neurosurgeons with support from device representatives and anesthesia as indicated.

Coding Specifications

Modifier	Description	When to Use
`26`

CPT 64617: Percutaneous Laryngeal Chemodenervation, Unilateral

CPT-64625-SACROILIAC-JOINT-RADIOFREQUENCY-ABLATION

CPT 64625: Sacroiliac Joint Radiofrequency Ablation

64643-DESTRUCTION-BY-NEUROLYTIC-AGENT-EG-CHEMICAL-THERMAL

CPT 64643: Neurolytic Destruction of Somatic Nerves

64633-DESTRUCTION-BY-NEUROLYTIC-AGENT-EG-CHEMICAL-THERMAL

CPT 64633: Neurolytic Destruction of Cervical/Thoracic Facet Joint Nerves

CPT-64600-TRIGEMINAL-NERVE-NEURODESTRUCTIVE-INJECTION

CPT 64600: Trigeminal Nerve Neurodestructive Injection

CPT-64611-SALIVARY-GLAND-CHEMICAL-DENERVATION-BILATERAL

CPT 64611: Bilateral Salivary Gland Injection to Reduce Saliva Production

CPT-64605-TRIGEMINAL-NERVE-NEURODESTRUCTIVE-INJECTION

CPT 64605: Trigeminal Nerve Neurodestructive Injection

CPT-64630-NEUROLYSIS-NERVE-DESTRUCTION-FOR-PAIN-MANAGEMENT

CPT 64630: Neurolysis for Pain Management

CPT-64644-CHEMICAL-INJECTION-FIVE-OR-MORE-MUSCLES-ONE-EXTREMITY

CPT 64644: Chemical Injection into Five or More Muscles of One Extremity

CPT-64636-LUMBAR-SACRAL-FACET-NEUROLYSIS-ADD-ON-LEVEL

CPT 64636: Lumbar/Sacral Facet Joint Neurolysis, Additional Level

Showing 1–10 of 26

Taxonomy Code	Specialty	Notes
207RH0000X	Cardiac Electrophysiology	Electrophysiologists commonly manage BAT devices and perform lead revisions.
2084P0800X	Vascular Surgery	Vascular surgeons may perform lead access, removal, or replacement in select cases.
2084N0400X	Neurosurgery	Neurosurgeons with experience in neuromodulation may perform BAT lead work.
207RN0400X	Cardiovascular Disease	Interventional cardiologists or heart failure specialists involved in BAT management.
207L00000X	Internal Medicine	Hospitalists or internists may coordinate perioperative medical management and optimization.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I10`	Essential (primary) hypertension	Primary indication for BAT in patients with resistant hypertension where lead revision may be required for device malfunction.
`I11.0`	Hypertensive heart disease with heart failure	BAT may be used for blood pressure modulation in patients with heart failure; lead issues necessitate revision.
`I50.9`	Heart failure, unspecified	Patients with heart failure may receive BAT; lead dysfunction requires surgical revision.
`I95.1`	Orthostatic hypotension	While less common, certain baroreflex therapies relate to autonomic dysfunction; lead revision relevant when device implanted for blood pressure regulation.
`Z45.018`	Encounter for adjustment and management of other cardiac device	Used for encounters related to management of implanted BAT systems; directly relevant to device lead revision and programming.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`33226`	Revision or replacement of pacemaker or cardioverter-defibrillator lead, open or percutaneous lead(s)	Similar lead revision procedures for cardiac implantable devices; analogous techniques and considerations when managing BAT leads.
`95970`	Electronic analysis of implanted neurostimulator pulse generator system (intracranial, spinal cord, peripheral nerve, or neurostimulator), single or multiple leads, without reprogramming; simple or initial interrogation	Used for device interrogation-only visits; intraoperative interrogation included in `64655` but outpatient interrogations may be separately reported when performed outside the operative service.
`95971`	Electronic analysis of implanted neurostimulator pulse generator system... with simple reprogramming	Postoperative or clinic reprogramming sessions that may occur after lead revision if done separately from the operative encounter.
`95972`	Electronic analysis of implanted neurostimulator pulse generator system... with complex reprogramming	Complex outpatient reprogramming sessions for BAT systems performed separate from the surgical encounter.
`64585`	Revision or replacement of peripheral nerve neurostimulator electrode array, open or percutaneous lead(s)	Another neuromodulation lead revision code providing clinical context for similar procedural steps and coding considerations.

OpenPayer